No evidence of oxidant events in amphotericin B cytotoxicity versus L. infantum promastigotes
Parasite, 8 4 (2001) 335-341
Published online: 2014-09-02
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Stigmasterol as a potential biomarker for amphotericin B resistance in Leishmania donovani
Rentala Madhubala, Rohini Muthuswami, Shib Sankar Sen and Ruby BansalJournal of Antimicrobial Chemotherapy 75 (4) 942 (2020)
https://doi.org/10.1093/jac/dkz515
Drug resistance and treatment failure in leishmaniasis: A 21st century challenge
Alicia Ponte-Sucre, Francisco Gamarro, Jean-Claude Dujardin, et al.PLOS Neglected Tropical Diseases 11 (12) e0006052 (2017)
https://doi.org/10.1371/journal.pntd.0006052
Amphotéricine B liposomale en première intention dans la leishmaniose viscérale infantile en région Provence–Alpes–Côte-d'Azur–Corse
P. Minodier, S. Robert, G. Noël, et al.Archives de Pédiatrie 12 (7) 1102 (2005)
https://doi.org/10.1016/j.arcped.2005.01.009
Leishmaniose viscérale infantile : nouvelles thérapeutiques
P Minodier, S Robert, K Retornaz and J.M GarnierArchives de Pédiatrie 10 s550 (2003)
https://doi.org/10.1016/S0929-693X(03)90036-4
Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patients
Philippe Minodier, Karine Retornaz, Alexia Horelt and Jean‐Marc GarnierFundamental & Clinical Pharmacology 17 (2) 183 (2003)
https://doi.org/10.1046/j.1472-8206.2003.00168.x